Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New NTRK1 inhibitors discovered by Luoxin Pharmaceutical, Shandong Luoxin Pharmacy Group

March 5, 2021

New JAK-1/TYK2 inhibitors synthesized at the National Institute of Pharmaceutical R&D

March 5, 2021

New CRL4 inhibitors show cytotoxicity tumors with low CUL4 expression

March 5, 2021

Antidiarrheal drug fights AML

March 5, 2021

CFI-402257 plus paclitaxel shows manageable safety in HER2-negative breast cancer patients

March 4, 2021

FDA clears initiation of phase I study of DT-2216 for solid tumors

March 4, 2021

MiR-939-5p, tumor suppressor and potential therapeutic target in TNBC

March 4, 2021

Wellmarker Bio receives phase I study approval for WM-S1-030 in Australia

March 4, 2021

Ankh Life Sciences describes new anticancer compounds

March 4, 2021

Cancer-associated fibroblasts influence GIST progression and metastasis through PDGFC secretion

March 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...